Receptor-mediated tumor targeting with radiolabeled peptides: there is more to it than somatostatin analogs.
Mariani
Giuliano
G
University of Pisa Medical School Pisa, Italy. g.mariani@med.unipi.it
Erba
Paola A
PA
Signore
Alberto
A
D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D007553:Isotope Labeling / Q000379:methods*; D009369:Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000378:metabolism*; D010455:Peptides / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011868:Radioisotopes / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics / Q000627:therapeutic use; D018000:Receptors, Peptide / Q000378:metabolism*; D013004:Somatostatin / Q000378:metabolism*
D010455:Peptides; D011868:Radioisotopes; D019275:Radiopharmaceuticals; D018000:Receptors, Peptide; D013004:Somatostatin